Special Survey on Parkinson's Disease Patients Treated Long-term Use of Pramipexole

Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD).

NCT00601523 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Long-term Daily Use of Mirapex®-LA Tablets in Patients With Parkinson's Disease

NCT01525641 ·Status: COMPLETED

Assessment of the Safety and Efficacy of Pramipexole Extended Release in Patients With Parkinson's Disease in Routine Clinical Practice

NCT01061567 ·Status: COMPLETED

a PMS on Safety Profile of Pramipexole in Chinese Parkinson Disease Patients

NCT01361009 ·Status: COMPLETED

Pramipexole Versus Placebo in Parkinson's Disease (PD) Patients With Depressive Symptoms

NCT00297778 ·Status: COMPLETED ·Phase: PHASE4

The Effect of Pramipexole on Metabolic Network Activity Compared With Levodopa in Early Parkinson's Disease

NCT01470859 ·Status: COMPLETED ·Phase: NA

Observational Study in Parkinson's Disease of the Primary Care Population of Patients Treated With Pramipexole

NCT02236728 ·Status: COMPLETED

Randomized Single-blind Placebo Controlled Comparative Trial of Pramipexole and Bromocriptine in Parkinson's Disease

NCT00240409 ·Status: COMPLETED ·Phase: PHASE3

Non-motor Symptoms (Depressive Symptoms) of Parkinson's Disease and Their Course Under Pramipexole Treatment

NCT00651183 ·Status: COMPLETED

Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's Disease

NCT01673724 ·Status: COMPLETED ·Phase: PHASE4

A Randomized, Double-blind, Active (Pramipexole 0.5 mg Tid) and Placebo Controlled, Study of Pramipexole Given 0.5 mg and 0.75 mg Bid Over 12-week Treatment in Early Parkinson's Disease (PD) Patients

NCT00402233 ·Status: COMPLETED ·Phase: PHASE4

Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD Patients

NCT00479401 ·Status: COMPLETED ·Phase: PHASE3

Pivotal Study in Advanced Parkinsons Disease Patients

NCT00466167 ·Status: COMPLETED ·Phase: PHASE3

Ophthalmologic Safety of Long Term Treatment With Pramipexole Compared to Bromocriptine or Other Dopamine Agonists in Patients With Parkinson's Disease

NCT02233023 ·Status: COMPLETED ·Phase: PHASE4

A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.

NCT03845387 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate in Patients With Parkinsonian Type Disorders

NCT03683225 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

SLV 308 and Pramipexole for Treatment of Patients With Early Parkinson Disease

NCT00335166 ·Status: COMPLETED ·Phase: PHASE3

Study of (Mirapex) Pramipexole for the Early Treatment of Parkinsons Disease (PD)

NCT00321854 ·Status: COMPLETED ·Phase: PHASE4

Prevent Cognitive Decline in GBA-associated Parkinson's Disease

NCT07055087 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Multiple Ascending Dose Study of PRX002 in Patients With Parkinson's Disease

NCT02157714 ·Status: COMPLETED ·Phase: PHASE1

Influence of Pramipexole Extended Release on Medication Adherence in Parkinson´s Disease

NCT01097421 ·Status: COMPLETED

Observational Study for Non-motor Symptoms and Treatment in Parkinson's Disease Patients

NCT02073981 ·Status: COMPLETED

Pramipexole Extended Release Versus Pramipexole Immediate Release for 18 Weeks in Chinese Parkinson's Disease (PD) Patients

NCT01191944 ·Status: COMPLETED ·Phase: PHASE3

Overnight Switch Trial From Pramipexole IR to Pramipexole ER in Patients With Early Parkinson Disease

NCT00558025 ·Status: COMPLETED ·Phase: PHASE3

A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's Disease

NCT01723904 ·Status: COMPLETED ·Phase: PHASE3